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Spirotenuipesines A and B, isolated from the entomopathogenic fungus Paecilomyces tenuipes by Oshima
and co-workers, have been synthesized. The synthesis features the highly stereoselective construction of
two vicinal all-carbon quaternary centers (C5 and C6) via an intramolecular cyclopropanation/radical
initiated fragmentation sequence and a diastereoselective intermolecular Diels-Alder reaction between
R-methylenelactone dienophile 20 and synergistic diene 6a. Installation of the C9 tertiary alcohol occurred
via nucleophilic methylation. An RCM reaction to produce a tetrasubstituted double bond in the presence
of free allylic alcohol and homoallylic oxygenated functional group is also described. This route shortened
the synthesis of 11 from 9 steps to 3 steps. We have further developed a strategy to gain access to
optically active spirotenuipesines A and B through the synthesis of enantioenriched 10 from commercially
available R-(-)-epichlorohydrin.
Introduction
Our laboratory has been exploring the therapeutic potential
of small molecule, nonpeptidyl, neurotrophically active agents.
It is well-known that naturally occurring, polypeptidyl neu-
rotrophic factors (such as NGF, BDNF, and GDNF) play a
central role in maintaining critical neurological functions.
1 These
neurotrophic factors are responsible for mediating neuronal
survival, differentiation, outgrowth, and apoptosis. Diminished
neurotrophic support has been linked to the progression of a
range of neurodegenerative disorders, including Alzheimer’s,
Parkinson’s, and Huntington’s diseases. Given their centrality
in maintaining proper neurological function, it is not surprising
that neurotrophic factors have been the focus of a great amount
of interdisciplinary research. Most efforts to date have centered
on exposing neurologically compromised subjects to naturally
occurring peptidyl neurotrophic factors, in the hopes of promot-
ing neurite outgrowth and survival.
2 However, this approach
suffers from some serious drawbacks. Most notably, these
polypeptidic agents generally exhibit unfavorable pharmacoki-
netic properties and require inconvenient drug-delivery tech-
niques, such as direct microinjection to the brain. An alternative
approach would be one in which the patient is treated with a
small molecule, nonpeptidyl agent that stimulates the production
of endogenous neurotrophic factors. Presumably, an appropri-
ately selected small molecule nonpeptidyl agent would be better
disposed to cross the blood-brain barrier.
Toward this end, we have taken note of a number of small
molecule natural products with demonstrated ability to enhance
neurite outgrowth, presumably through the induction of key
neurotrophic factors.
3 To date, we have synthesized and
evaluated a range of these neurologically active small molecules,
including tricycloillicinone,
4 merrilactone A,
5 scabronine G
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6 NGA0187,
7 jiadifenin,
8 11-O-debenzoyltashiro-
nin,
9 garsubellin A,
10 and paecilomycine A.
11 Our involvement
in this ﬁeld also led us to pursue the total synthesis of the
structurally complex small molecule neurotrophins, spiro-
tenuipesines A and B.
12
Spirotenuipesines A (1a)a n dB( 1b) were isolated from the
entomopathogenic fungus, Paecilomyces tenuipes by Oshima
and co-workers in 2004.
13 The researchers found that, upon
introduction to 1321N1 human astrocytoma cells, both natural
products appeared to facilitate the expression and release of key
neurotrophic factors, as evidenced by the ability of the cells to
then promote the neuronal differentiation of rat pheochromocy-
toma cells (PC-12). We recently launched an investigation
toward the total synthesis of spirotenuipesines A and B, in the
hopes of identifying lead candidates for further biological
investigations against neurodegenerative disorders.
Structurally, spirotenuipesines A (1a)a n dB( 1b), are uniquely
cyclized trichothecanes
14 containing spirocyclic, tricyclo ring
systems. The ﬁrst-generation total syntheses of spirotenuipesines
A and B were completed in 2007.
12 We describe herein the
details of the total syntheses of these challenging natural
products, and the way in which each stereocenter was installed
in an efﬁcient and selective manner. We further disclose an
asymmetric strategy by which to gain access to optically active
natural product.
Results
A First-Generation Strategy for the Synthesis of Spiro-
tenuipesines A and B. Our general strategy toward spiro-
tenuipesines A (1a)a n dB( 1b) is outlined in Scheme 1. A key
feature of the synthesis would be a Diels-Alder reaction
between an R-methylenelactonic dienophile (see 5) and a
synergistic diene
15 (i.e., 6). Cycloaddition would presumably
occur from the convex face of the bicyclic system. Following
unraveling of the primary adduct, enone 7 would be produced.
This intermediate would be advanced to spirotenuipesine A (1a)
through a sequence which includes functionalization of C9,
reduction of the C15 lactonic carbonyl group, followed by acetal
formation between the C3 hydroxyl group and C15, disposed on
the concave face of the molecule. In contemplating the synthesis
of the potential Diels-Alder dienophile, 5, we anticipated that
the lactone functionality (4) could be installed through an as-
yet unspeciﬁed oxidative lactonization protocol (3 f 4). From
the outset, it was presumed that precursor 3 might be generated
through a Claisen-like rearrangement of an allylic alcohol of
the type 2. It was further supposed, with what was ultimately
revealed to be unwarranted optimism, that the sigmatropic
rearrangement would occur with high stereoselectively anti to
the resident protected alcohol. Operating under the Claisen
rearrangement paradigm, the need for an eventual inversion of
conﬁguration at C3 (i.e., 2 f 4) was anticipated.
Studies Directed toward a Stereoselective Claisen Rear-
rangement. Our synthesis of the pre-Claisen rearrangement
substrate (11) commenced with the known dienol 8,
16 which
was protected as the -TBS ether to provide 9 (Scheme 2).
Catalytic oxidation with selenium dioxide on silica gel (5%)
17
mediated by tert-butylhydrogen peroxide as a co-oxidant
afforded the desired allylic alcohol 10. In an effort to achieve
maximum efﬁciency, we evaluated the feasibility of executing
the ring-closing metathesis directly with the unprotected allylic
alcohol 10. We were pleased to ﬁnd that when diene 10 was
heated in benzene under reﬂux, with slow addition of the Grubbs
second-generation catalyst,
18 the cycopentenyl adduct 11,
incorporating a tetrasubstituted oleﬁn, was isolated in 82% yield.
It should be noted that the RCM route described here constitutes
a major simpliﬁcation to the preparation of 11. Under this
protocol, adduct 11 was accessed in 35% overall yield in three
steps, while the previously reported literature procedure requires
nine steps for the synthesis of this key intermediate.
19 This
protocol also represents one of only a few instances in which
RCM has been employed to generate a tetrasubstituted oleﬁn.
20
With 11 in hand, we now turned our attention to the key
Claisen rearrangement. To our surprise, the key rearrangement
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SCHEME 1. Synthetic Strategy toward Spirotenuipesines A
and B
SCHEME 2. Nonstereoselective Claisen Rearrangement
a
a Reagents and conditions: (a) TBSCl (1.0 M in THF, 1.2 equiv), imid.
(1.2 equiv), DMF, rt, overnight, 95%; (b) 5% SeO2 on silica gel (0.05 equiv),
t-BuOOH (5-6 M in nonane, 2.5 equiv), CH2Cl2, rt, 2 days, 40-50%; (c)
Grubbs second-generation catalyst (0.05 equiv), benzene, reﬂux, 3-4h ,
82%; (d) propionic acid (0.06 equiv), triethyl orthoacetate (7.0 equiv), 180
°C, 2 days, 87%, 1:1 dr.
Total Synthesis of Spirotenuipesines A and B
J. Org. Chem. Vol. 73, No. 24, 2008 9577proved problematic: all of our efforts to effect an Ireland-
Claisen
21 rearrangement of 11 were fruitless. Attempts to
employ the Still
22 and Inanaga protocols
23 to introduce the
methylene group directly were also unproductive. Fortunately,
we were able to achieve rearrangement through the use of the
Johnson-Claisen protocol.
24 Surprisingly, at the time, the
quaternary carbon center was elaborated with a complete lack
of diastereoselectivity (12a:12b ) 1:1). In an attempt to achieve
some level of diastereoselectivity, we replaced the silyl protect-
ing group on the secondary alcohol with more electron-deﬁcient
functionalities, such as acetate. The hope was that this type of
functionality might exhibit some electronic interaction with the
electron-rich ketene acetal moiety. However, under all conditions
examined, the rearrangement gave 1:1 mixtures of rearranged
products.
The diastereomeric mixture of 12a and 12b was transformed
to carboxylic acids 13a/13b through a two-step protocol
involving DIBAL-H reduction and Pinnick oxidation (Scheme
3).
25 Subsequent iodolactonization afforded a separable mixture
of iodides 14a and 14b in 76% yield over three steps.
26 The
relative stereochemistry of 14b was conﬁrmed by X-ray
crystallography. Aerobic tin hydride-mediated radical reactions
27
served to convert the iodolactones (14a and 14b) to hydroxy-
lactones (15a and 15b, respectively). Interestingly, we also found
that when the 1:1 mixture of 13a and 13b was treated with
m-CPBA in CH2Cl2, only 15a was obtained, in 30% yield.
Presumably it is the product of direct hydroxylactonization,
28
without the intermediate formation of epoxide. We speculate
that diastereomer 13b, which does not react under these
conditions, most likely would suffer from prohibitive steric
interactions in positioning the large -TBS-protected hydroxyl
group in the concave face in the transition state (see 15b-TS).
In fact, the observed result supports the notion of a direct
hydroxylactonization pathway. A hypothetical intermediate
epoxide would have been expected to emerge on the face
opposite the resident TBS ether group. Subsequent epoxide ring
opening by the intramolecularly appended carboxylate would
produce 15b, rather than the observed product 15a.
To gain access to sufﬁcient quantities of dienophile 20 to
explore the key Diels-Alder reaction, lactones 15a and 15b
were separately advanced to the same intermediate, 16b.A s
outlined in Scheme 4, the free alcohols of 15a and 15b were
protected as the PMB ethers.
29 Epimer 16a was then converted
to intermediate 16b through a Mitsunobu reaction,
30 which
served to invert the stereocenter at the carbon bearing the
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Kraus, G. A.; Roth, B. J. Org. Chem. 1980, 45, 4825. (c) Bal, B. S.; Childers,
W. E.; Pinnick, H. W., Jr. Tetrahedron 1981, 37, 2091.
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1988, 29, 4139.
(30) Mitsunobu, O. Synthesis 1981,1 .
SCHEME 3. Hydroxylactonization vs Iodolactonization
a
a Reagents and conditions: (a) DIBAL-H (1.0 M in toluene, 1.1 equiv), CH2Cl2, -78 °C, 20 min; (b) NaClO2 (6.0 equiv), NaH2PO4-H2O (6.0 equiv),
2-methyl-2-butene (2.0 M in THF, 8.0 equiv), t-BuOH, rt, 5 h; (c) NaHCO3 (3.0 equiv), KI (1.3 equiv), I2 (1.3 equiv), THF, rt, overnight, 76% over three
steps; (d) mCPBA (1.2 equiv), CH2Cl2,0°C to rt, 30% for 15a; 0% for 15b; (e) AIBN (1.0 equiv), Bu3SnH (3.0 equiv), dry air, toluene, 60 °C, 2 days; then
NaBH4 (2.0 equiv), EtOH, 0 °C ,2h ,7 5 -78%.
SCHEME 4. Synthesis of Dienophile 20
a
a Reagents and conditions: (a) PMB trichloroacetimidate (1.2 equiv), CSA (0.1 equiv), CH2Cl2, rt, overnight, 95%; (b) TBAF (1.0 M in THF, 2.0 equiv),
THF, rt, overnight, 87%; (c) PPh3 (1.2 equiv), PhCOOH (1.2 equiv), DIAD (1.2 equiv), toluene, rt, 3 h; (d) K2CO3 (1.0 equiv), MeOH, rt, 7 h, 98%; (e)
TBSOTf (2.0 equiv), 2,6-lutidine (20 equiv), CH2Cl2,0°C to rt, overnight, 95%; (f) LDA (1.2 equiv), THF, -78 °C, 30 min; then CH2O (gas), 0 °C, 5 min;
then rt, overnight, 19: 65%, 20: 28%; (g) MsCl (2.0 equiv), TEA (4.0 equiv), CH2Cl2,0°C to rt, 4 h; then, DBU (3.0 equiv), CH2Cl2, 3 h, rt, 95%.
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ment adjacent to the R-carbon of lactone 16b, we elected to
employ Grieco’s protocol
31 to elaborate 16b to the R-methylene
lactone 20. The expected hydroxymethyl lactone 19 was
obtained in 65% yield, along with 28% of R-methylene lactone
20. Compound 19 was then fully converted to 20 in 95% yield
through standard mesylation followed by base induced  -elim-
ination. It is worth mentioning in passing that the hindered
R-methylene could not be installed through the use of Eschen-
moser’s salt
32 or Bredereck’s reagent.
33
Intramolecular Cyclopropanation and Radical-Initiated
Fragmentation. Although we could, in practice, reincorporate
each of the Claisen adducts (12a and 12b) into our synthesis
through a multistep process (Scheme 4), this strategy would
force us to compromise in terms of both synthetic efﬁciency
and aesthetic standards. Upon reﬂection, we began to consider
an alternative means by which we might stereoselectively gain
access to our target γ,δ-unsaturated esters. As outlined in
Scheme 5, we envisioned that bicyclo compound 21 could be
obtained from [3.2.1]bicyclolactone 22 due to the cis-relation-
ship between the highlighted carboxylate and secondary alcohol
moieties. Presumably, 22 could be accessed through a reductive
or radical-based ring opening of the cyclopropane ring in
compound 23, operating through cleavage of the Walsh bond.
34
The latter, in turn, would be assembled through an intramo-
lecularly tethered cyclopropanation of 24 (itself derived from
11). Through such an intramolecular cyclopropanation, we
hoped to secure the critical cis-relationship between the 2-carbon
carboxylate and the secondary hydroxyl group. It was this
deﬁned stereochemical relationship which had eluded us under
the original Claisen paradigm.
The modiﬁed route (see Scheme 6) commenced with the
previously synthesized compound 11. The latter was advanced
to 25 through a straightfoward sequence consisting of protection
of the primary alcohol, removal of the TBS protecting group,
and installation of the diazoacetic ester through the Corey-Myers
modiﬁed House’s procedure.
35 Upon thermal decomposition in
the presence of catalytic bis(N-tert-butylsalicylaldiminato)cop-
per(II) in toluene, diazoester 25 smoothly underwent intramo-
lecular cyclopropanation to provide the activated cyclopropane
26 in excellent yield.
36 We note that no dimerization or C-H
insertion products were observed when copper(II) was used as
catalyst, though we did ﬁnd slow introduction of diazoester 25
into the reaction to be critical. In screening various reaction
conditions for reductive ring-opening fragmentation, it seemed
to us that Li/NH3 was the most efﬁcient reducing system, though
affording only a 30% yield of 29. Furthermore, the reaction
suffered from poor reproducibility. Accordingly, we sought an
alternate fragmentation protocol. Upon further investigation, we
identiﬁed a reliable route from 26 to 29. Thus, selective K2CO3-
mediated deprotection of the acetate in the presence of the
strained lactone afforded primary alcohol 27, which was then
readily transformed to xanthate 28. Finally, Barton-McCombie
deoxygenation
37 triggered the tandem radical process, giving
rise to [3.2.1]bicyclolactone 29 in over 60% yield for three steps.
Hydrolysis of 29 followed by iodolactonization
38 and TBS
protection afforded intermediate 14b, which could be trans-
formed to dienophile 20 using the chemistry described above
(Schemes 3 and 4).
It is instructive to reﬂect on the implications of the interplay
between the Claisen and cyclopropanation routes. Consider
substrate 11; under the Claisen protocol, this starting material
(31) (a) Grieco, P. A. Synthesis 1975, 67. (b) Crimmins, M. T.; DeLoach,
J. A. J. Am. Chem. Soc. 1986, 108, 800.
(32) (a) Danishefsky, S.; Schuda, P. F.; Kitahara, T.; Etheredge, S. J. J. Am.
Chem. Soc. 1977, 99, 6066. (b) La Clair, J. J.; Lansbury, P. T.; Zhi, B. X.;
Hoogsteen, K. J. Org. Chem. 1995, 60, 4822.
(33) Marcos, I.; Redero, E.; Bermejo, F. Tetrahedron Lett. 2000, 41, 8451.
(34) Walsh, A. D. Nature 1947, 159, 165 and 712.
(35) (a) House, H. O.; Blankley, C. J. J. Org. Chem. 1968, 33, 53. (b) Corey,
E. J.; Myers, A. G. Tetrahedron Lett. 1984, 25, 3559.
(36) Danishefsky, S. J. Acc. Chem. Res. 1979, 12, 66.
(37) Barton, D. H.; McCombie, S. W. J. Chem. Soc., Perkin Trans. 1 1975,
1574.
(38) Corey, E. J.; Weinshenker, N. M.; Schaaf, T. K.; Huber, W. J. Am.
Chem. Soc. 1969, 91, 5675.
SCHEME 5. Intramolecular Cyclopropanation and Ring-Opening Fragmentation
SCHEME 6. Synthesis of Dienophile 20 via Cyclopropanation and Fragmentation
a
a Reagents and conditions: Key: (a) Ac2O, DMAP, TEA, CH2Cl2, rt; TBAF, THF, rt, 84% over two steps; (b) glyoxylic acid chloride tosylhydrazone,
N,N-dimethylaniline; TEA, CH2Cl2,0°C to rt, 88%; (c) bis(N-tert-butylsalicylaldiminato)copper(II), tol., reﬂux, (slow addition of starting material), 91%;
(d) Li/NH3, THF, -78 °C to reﬂux, 1 h, 0-30%; (e) K2CO3, MeOH, rt; (f) KHMDS; CS2; MeI, THF, rt; (g) n-Bu3SnH, AIBN, tol., 110 °C, 5 h, 60% over
three steps; (h) KOH, MeOH, 60 °C; HCl, then NaHCO3, KI, I2, THF, rt; (i) TBSOTf, 2,6-lutidine, CH2Cl2,0°C to rt, 77% over three steps.
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lation (see 13, Scheme 7). Subsequently, through formal
oxylactonization, 15 is produced. In sum, there has been
accomplished the equivalent of a cis-hydroxycarboxymethyla-
tion. However, the relationship between the lactone and the
resident OTBS group is not speciﬁed. By contrast, the tethered
cyclopropanation route leads to 26. Subsequent site-speciﬁc
vicinal reductive cleavage again accomplishes overall cis-
hydroxycarboxymethylation (see 15) with the important proviso
that the cis-bridgehead substituents are now disposed syn to
the OTBS group.
Completion of the Total Synthesis of Spirotenuipesines
A and B. With an efﬁcient and stereoselective synthesis of
dienophile 20 accomplished, we now turned our attention to
the critical Diels-Alder reaction. It was anticipated that 20 and
6a would undergo a diastereoselective Diels-Alder cycload-
dition, wherein the diene 6a would approach from the much
less hindered convex face of dienophile 20. The resident TBS
SCHEME 7. Claisen vs Tethered Cyclopropanation Strategy
SCHEME 8. Diels-Alder Reaction and Transannular Acetal Formation
a
a Reagents and conditions: (a) 6a (10 equiv), methylene blue (0.01 equiv), toluene, 180 °C, 2 days; (b) Amberlite I-120 (acidic), CH2Cl2, rt, 30 min, 90%,
8:1 dr; (c) Ph3P+CH3I- (6.0 equiv), KHMDS (0.5 M in toluene, 5 equiv), -78 °C; then rt overnight, 96%; (d) TBAF (1.0 M in THF, 2.0 equiv), THF, rt,
1 h, 97%; (e) DIBAL-H (1.0 M in toluene, 2.2 equiv), CH2Cl2, -78 °C, 20 min; (f) CSA (0.36 equiv), 4 Å MS, CH2Cl2, rt, 75 min, 90%.
SCHEME 9. Nonstereoselective Introduction of C9 Stereocenter
a
a Reagents and conditions: (a) OsO4 (0.05 M in toluene, 1.1 equiv), pyridine, rt, 1.5 h; (b) MsCl (20 equiv), pyridine (40 equiv), CH2Cl2, 15 h, rt, 81%;
(c) Super-H (1.0 M in THF, 4.0 equiv), THF, 0 °C, 45 min, 62%; (d) DDQ (2.0 equiv), CH2Cl2/buffer solution pH ) 7.00 (18:1), rt, 5 h, 80%.
SCHEME 10. Stereochemical Analysis at C9
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9580 J. Org. Chem. Vol. 73, No. 24, 2008ether located on the concave face of dienophile 20 would be
expected to reinforce the sense of diastereoselectivity. Not
surprisingly, the desired cycloadduct 30 was obtained upon
heating diene 6a and dienophile 20 in toluene, with methylene
blue as stabilizer (Scheme 8). The cycloadduct 30 formed as a
mixture of stereoisomers. Without further puriﬁcation, both
components were hydrolyzed by acidic Amberlite I-120 to afford
a separable mixture of enones (dr 8:1), from which the desired
epimer, 31, was isolated in 80% yield.
We hoped next to convert the C9 ketone function to a terminal
oleﬁn group and to install the requisite C3-C15 transannular
acetal functionality. Thus, enone 31 was advanced to 32 through
Wittig methenylation followed by removal of the -TBS protect-
ing group. Subsequent lactone reduction afforded hemiacetal
33 as a 2:1 mixture of isomers. Somewhat surprisingly, 33 is
apparently quite stable, and only trace amounts of material
cyclized spontaneously after 2 days at room temperature. Upon
exposure to catalytic amounts of camphorsulfonic acid and
molecular sieves for 1 h, transannular acetal 34 was obtained
in 90% yield.
The ﬁnal challenge to be faced was that of installing the tertiary
alcohol at C9 with the required stereochemistry. We ﬁrst considered
a straightforward strategy involving oxidation of the exo-methylene
group of 34. However, all efforts to epoxidize the exo-methylene
group were unsuccessful, and chemoselective dihydroxylation using
OsO4 in pyridine afforded a 2:1 mixture of diastereomers (35b
and 35a, Scheme 9). Upon mesylation, followed by superhydride
reduction and removal of the PMB ether, we learned that the
major epimer (35b) was the undesired one, leading to formation
of 9-epi-spirotenuipesine. It would seem that the tert-butyl-like
large group (RL)a tC 5 locks the conformation of the cyclohex-
enyl ring, forcing C15 (RS) into a pseudo-axial position. Thus,
OsO4 approaches the exomethylene group from its outside axial
face, presumably in order to avoid torsional strain. The major
product is 35b (Scheme 10). It seemed that, by reversing the
sequence of introduction of the methyl and hydroxyl groups,
we would be able to establish the stereochemistry at C9 in the
desired sense. As depicted in Scheme 10, path b, a generic
methyl nucleophile (MeM) would be expected to deliver the
methyl group through axial attack of ketone 37, giving the
desired 36a as the major product.
To test this hypothesis, we converted 34 to 37 through
dihydroxylation followed by oxidative cleavage (Scheme 11).
39
Diastereoselective nucleophilic methylation was accomplished
through the action of methyllithium and ceric chloride,
40 thereby
affording 36a in 82% yield with 6:1 stereoselection in the
desired sense. Higher ratios of diastereoselection could be
achieved (16:1), though in reduced yield, with methylmagnesium
bromide (73%) (Table 1 in Scheme 11). As hoped, it was found
that stereoselection does indeed favor attack of the nucleophile
from the axial face, wherein the sp3 spiro center serves as an
equatorially based conformational lock. The total synthesis of
spirotenuipesine A (1a) was now completed upon removal of the
PMB group, as shown. In addition to the congruencies of the
spectral properties with those of natural product, our assignments
are secured by a crystallographic determination of fully synthetic
1a. Parenthetically, we note that we could convert 1a to 1b
following a reported protocol.
13
Asymmetric Synthesis of Spirotenuipesines A and B. Upon
completion of the syntheses of racemic spirotenuipesine A (1a)
a n dB( 1b), we devised a second-generation asymmetric route.
In examining our ﬁrst-generation synthesis, we focused on
reaching dienyl alcohol 10 or cyclopentenyl alcohol 11 in
optically active form. With the absolute stereochemistry of the
secondary alcohol established at an early stage of the synthesis,
we could be conﬁdent that our ﬁrst-generation diastereoselective
route would enable the installation of the subsequent stereo-
centers in the desired sense. Two possible strategies for the
synthesis of enantioenriched or enantiopure 11 presented
themselves (Scheme 12). Both routes would begin with readily
available optically active (R)-epichlorohydrin (38). The ﬁrst
(path a) envisions sequential openings of 38, ﬁrst with isopro-
penyl cuprate 39 and then with functionalized isopropenyl
cuprate 40, as shown, to ultimately give rise to an intermediate
of the type 41. The unspeciﬁed “X” group would be transformed
into a hydroxyl group to afford substrate 10, which is the
precursor for the previously discussed RCM reaction. In an
alternate route (path b), sequential opening of 38 with isopro-
penyl cuprate 39 and acetylide 42 would eventually afford an
intermediate of the type 43. Ring-closing enyne metathesis
(39) Garlaschelli, L.; de Tullio, P.; Vidari, G. Tetrahedron 1991, 47, 6769.
(40) Imamoto, T.; Takiyama, N.; Nakamura, K.; Hatajima, T.; Kamiya, Y.
J. Am. Chem. Soc. 1989, 111, 4392.
SCHEME 11. Completion of the Total Synthesis of Spirotenuipesine A and B
a
a Reagents and conditions: (a) OsO4 (0.05 M in toluene, 1.1 equiv), pyridine, rt, 1.5 h; (b) NaIO4, THF/H2O (1:1), 0 °C to rt, 2 h, 90%; (c) CH3M (see
Table 1 above, 10 equiv), THF, -78 °C, then 0 °C, 3 h; (d) DDQ (2.0 equiv), CH2Cl2/buffer solution pH ) 7.00 (18:1), rt, 5 h, 80%; (e) Oxone (12.5 equiv),
CH2Cl2/MeOH/phosphate buffer (pH 9.2)/acetone (1:4:2:0.3), 0 °C, 6 h, 91%.
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of the terminal oleﬁn, would provide 11.
As shown in Scheme 13, the viability of path a was
investigated. Following treatment with isopropenyl cuprate,
R-(-)-epichlorohydrin underwent the desired epoxide ring
opening/ring closure sequence to afford 45. Our preliminary
efforts to attack the newly generated epoxide of 45 with cuprate
reagents derived from 2-bromoprop-2-en-1-ol
41 or its ethers (cf.
47) were unsuccessful, presumably due to low reactivity or to
1,2-elimination of the cuprate, which would lead to unproductive
formation of allene.
42,43 An alternate cuprate reagent, derived
from 1-bromo-1-trimethylsilylmethylethene,
44 was chosen to
avoid the problem of 1,2-elimination. The expectation was that
the TMS group could be subsequently transformed into the
requisite hydroxyl group.
45 As shown in Scheme 13, under these
conditions compound 48 was formed in excellent yield from
45 through a two-step sequence of cuprate addition and
protection of the resultant secondary alcohol. Upon exposure
to PhSeCl and subsequent H2O2 oxidation, the optically active
alcohol 10 was generated. We noted that this two-step sequence
provided a general solution to the problem of 1,2-elimination
of metallo-reagents bearing oxygenated leaving groups. With
an efﬁcient route to enantioenriched 10 in hand, we are conﬁdent
that we now have means by which to gain entry into the optically
active series of spirotenuipesines A and B.
Conclusion
In summary, the syntheses of spirotenuipesines A (1a) and
B( 1b) have been accomplished. Key features of the synthesis
include (1) the development of an improved RCM route to the
tetrasubstituted cyclopentenyl system, 11, (2) the diastereose-
lective synthesis of the key bicyclic lactone 21 through recourse
to a tethered cyclopropanation strategy, and (3) the stereose-
lective assembly of the spirocyclic system through Diels-Alder
reaction between R-methylenelactone dienophile 20 and syn-
ergistic diene 6a.
46 We have further developed a strategy by
which to access optically active spirotenuipesines A and B
through the synthesis of enantioenriched 10.
At a biological level, the concise stereocontrolled total
syntheses have allowed us access to sufﬁcient quantities of
material to begin to study the biological activity of these
compounds. Biological studies are underway and will be
reported in due course.
Experimental Section
(R)-2-(2-Methylallyl)oxirane (45). To a suspension of CuI (1.73
g, 9.08 mmol) in Et2O (90 mL) was added 2-propenylmagnesium
bromide (0.5 M in THF, 100 mL, 50 mmol) at -78 °C. The
resulting mixture was placed in a -30 °C bath for 15 min, and
then R-(-)-epichlorohydrin (3.56 mL, 45.4 mmol) was added
dropwise. The mixture was stirred for 30 min at -30 to -20 °C,
by which time the initial yellow-orange color had turned to black.
The reaction was quenched with saturated aqueous NH4Cl and
washed with 4 × 20 mL of H2O to give 6.2 g chlorohydrin as a
colorless oil, which by 1H NMR contained a small amount of THF
but was otherwise pure. 1H NMR (500 MHz, CDCl3): 4.91 (s, 1H),
4.83 (s, 1H), 3.98 (m, 1H), 3.63 (dd, J ) 11.1, 3.8 Hz, 1H), 3.53
(dd, J ) 11.1, 6.4 Hz, 1H), 2.30 (m, 2H), 2.18 (d, J ) 3.9 Hz,
1H), 1.78 (s, 3H).
The above crude chlorohydrin (6.2 g, ∼45 mmol) was dissolved
in 50 mL of CH2Cl2, crushed NaOH pellets (3.6 g, 90 mmol) were
added, and the resulting suspension was stirred at room temperature
for 24 h (reaction was monitored by 1H NMR of aliquots). MgSO4
was then added, and the reaction mixture was ﬁltered and
(41) Cousseau, J. Synthesis 1980, 805.
(42) (a) Corey, E. J.; Widiger, G. N. J. Org. Chem. 1975, 40, 2975. (b) Corey,
E. J.; Cane, D. E.; Libit, L. J. Am. Chem. Soc. 1971, 93, 7016.
(43) We also made enyne intermediate A by the following sequential epoxide
ring openings with following deprotection and protection procedures. However,
enyne metathesis of A gave diene B as a minor product as well as triene C as
major product. The difﬁculties encountered by selective oxidative cleavage of
B and C discouraged us from further pursuing this route.
(44) (a) O’Brien, M.; Taylor, N. H.; Thomas, E. R. Tetrahedron Lett. 2002,
43, 5491. (b) Williams, D. R.; Kiryanov, A. A.; Emde, U.; Clark, M. P.; Berliner,
M. A.; Reeves, J. T. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12058.
(45) Nishiyama, H.; Itagaki, K.; Sakuta, K.; Itoh, K. Tetrahedron Lett. 1981,
22, 5285.
(46) For earlier precedents: (a) Schlessinger, R. H.; Nugent, R. A. J. Am.
Chem. Soc. 1982, 104, 1116. (b) Roush, W. R.; Sciotti, R. J. J. Am. Chem. Soc.
1998, 120, 7411.
SCHEME 12. Synthetic Plan for the Asymmetric Synthesis of Spirotenuipesines A and B
SCHEME 13. Asymmetric Synthesis of 10
a
a Reagents and conditions: (a) CuI cat., 2-propenylmagnesium bromide,
Et2O -78 to -30 °C, 15 min; then R-(-)-epichlorohydrin, -30 to -20
°C; (b) NaOH, CH2Cl2, 24 h, 58% for two steps; (c) Mg (0), 1,2-
dibromoethane, 1-bromo-1-trimethylsilylmethylethene, reﬂux, THF; epoxide
45, CuI, THF, -60 °C, 2 h, 98%; (d) TBSCl, imidazole, DMF, 0 °Ct or t ,
24 h, 93%; (e) PhSeCl, SnCl2 cat., CH2Cl2, -78 to 0 °C, 23 min; then 30%
(wt) H2O2, pyridine, CH2Cl2, 20 min, 73%.
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The remaining small amount of THF was removed by a short
column of SiO2, eluting with 5:1 pentane/Et2O. Fractions were
concentrated to remove almost all solvent at 30 °C/450 mmHg.
The ﬁnal 2-3 mL solvent was removed by evaporation under N2
stream to give pure, solvent-free epoxide 45, 2.6 g (58% over two
steps) as a colorless volatile oil. [R]22.8
D +2.7 (c 1.17, CHCl3). 1H
NMR (400 MHz, CDCl3): 4.83 (app s, 2H), 3.03 (m, 1H), 2.79
(dd, J ) 4.8, 4.0 Hz, 1H), 2.50 (dd, J ) 2.8, 5.2 Hz, 1H), 2.28 (dd,
J ) 15.2, 6.0 Hz, 1H), 2.19 (dd, J ) 15.2, 5.2 Hz, 1H), 1.80 (s,
3H). 13C NMR (100 MHz, CDCl3): 141.2, 112.1, 51.1, 46.9, 40.8,
23.0. MS (APCI+): calcd for C6H11O( M+ H) 99.07, found 99.23.
(R)-2-Methyl-6-((trimethylsilyl)methyl)hepta-1,6-dien-4-ol. Mag-
nesium turnings (1.24 g, 51.8 mmol) were ﬂame-dried under an
argon atmosphere. After the mixture was cooled to room temper-
ature, THF (5 mL) was added. To this mixture was added 1,2-
dibromoethane (50 µL) to activate the magnesium turnings. Neat
1-bromo-1-trimethylsilylmethylethene (1.0 g, 5.18 mmol) was added
slowly (15 min). Reﬂux was maintained for another 30 min.
To a cold (-60 °C) solution of epoxide 45 (270 mg, 2.75 mmol)
in THF (5 mL) was added copper(I) iodide (74.5 mg, 0.39 mmol).
The above Grignard solution in THF was added quickly to the
suspension. A THF rinse (3 mL) of the Grignard solution was also
added to the suspension. After the reaction was warmed from -60
°C to room temperature over 2 h, the mixture was quenched with
aqueous saturated NH4Cl. The mixture was diluted with ether,
washed with aqueous saturated NH4Cl and brine, dried over MgSO4,
ﬁltered, and concentrated. The residue was puriﬁed by ﬂash
chromatography (hexane/ethyl acetate: 12/1) to give the desired
product (573 mg, 98%). [R]21.8
D +13.5 (c 0.53, CHCl3). 1H NMR
(400 MHz, CDCl3): 4.87 (s, 1H), 4.81 (s, 1H), 4.71 (s, 1H), 4.69
(s, 1H), 3.89 (m, 1H), 2.06-2.21 (m, 4H), 1.99 (s, 1H), 1.79 (s,
3H), 1.61 (d, J ) 13.2 Hz, 1H), 1.55 (d, J ) 13.2 Hz, 1H), 0.05 (s,
9H). 13C NMR (100 MHz, CDCl3): 144.5, 142.7, 113.0, 110.1, 66.5,
46.0, 45.5, 26.7, 22.5, -1.5. MS (APCI+): calcd for C12H23OSi
(M - H) 211.16, found 211.23.
(R)-tert-Butyldimethyl(2-methyl-6-((trimethylsilyl)methyl)hepta-
1,6-dien-4-yloxy)silane (48). To a solution of the above material
(124 mg, 0.585 mmol) in 3 mL of DMF were added imidazole (80
mg, 1.17 mmol) and TBSCl (106 mg, 0.70 mmol) at 0 °C. The
reaction mixture was allowed to warm to room temperature and
stirred overnight. The reaction was quenched with 20 mL of water
and extracted with ether (3 × 20 mL). The combined organic phases
were washed with water and brine, respectively, dried over MgSO4,
and concentrated to give 48 (178 mg, 93%) without further
puriﬁcation. [R]21.3
D +1.84 (c 1.24, CHCl3). 1H NMR (400 MHz,
CDCl3): 4.78 (s, 1H), 4.72 (s, 1H), 4.63 (s, 1H), 4.58 (s, 1H), 3.93
(m, 1H), 2.08-2.24 (m, 4H), 1.74 (s, 3H), 1.55 (d, J ) 13.6 Hz,
1H), 1.51 (d, J ) 13.6 Hz, 1H), 0.89 (s, 9H), 0.05 (s, 6H), 0.02 (s,
9H). 13C NMR (100 MHz, CDCl3): 144.4, 142.9, 113.0, 109.9, 70.0,
46.1, 27.1, 25.9, 23.0, 18.1, -1.1, -1.4, -4.4, -4.5. MS (APCI+):
calcd for C18H39OSi2 (M + H) 327.2, found 327.4.
(R)-4-(tert-Butyldimethylsilyloxy)-6-methyl-2-methylenehept-6-
en-1-ol (10). To a solution of 48 (56 mg, 0.17 mmol) in 3 mL of
CH2Cl2 were added PhSeCl (28 mg, 0.143 mmol) and a catalytic
amount of SnCl2 at -78 °C. The reaction was stirred at -78 °C
for 17 min, warmed to 0 °C, and stirred for another 23 min. After
the solvent was removed, the residue was put on a Florisil column
for 15 min. The selenide was washed off the column with hexane/
ethyl acetate (10/1). After concentration, the selenide was subse-
quently treated with 30% (wt) H2O2 (162 mg, 1.43 mmol) and
pyridine (23 µL) in CH2Cl2 (3 mL) at 0 °C for 20 min. The reaction
mixture was quenched with aqueous 20% Na2S2O3, diluted with
ether, washed with 20% Na2S2O3, 1 N HCl, aqueous saturated
NaHCO3, and brine, dried over MgSO4, ﬁltered, concentrated, and
puriﬁed by ﬂash chromatography (hexane/ethyl acetate: 8/1) to give
desired product 10 (34 mg, 88% based on PhSeCl or 73% based
on 48). [R]23.3
D +22.3 (c 0.93, CHCl3). 1H NMR (400 MHz,
CDCl3): 5.11 (s, 1H), 4.90 (s, 1H), 4.80 (s, 1H), 4.73 (s, 1H), 4.05
(d, J ) 6.40 Hz, 2H), 3.98 (m, 1H), 2.81 (t, J ) 6.40 Hz, 1H),
2.26 (m, 4H), 1.73 (s, 3H), 0.90 (s, 9H), 0.08 (s, 6H). 13C NMR
(100 MHz, CDCl3): 145.6, 142.2, 114.0, 113.3, 70.4, 66.4, 45.2,
41.1, 25.8, 22.8, 18.0, -4.66, -4.71. HRMS (FAB+): calcd for
C15H31O2Si 271.2093, found 271.2079.
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